The DOI matches its Crossref record; 125 of the 125 references it cites were found in a registry or an index.
Positive and Negative Modulation of Angiogenesis by VEGFR1 Ligands
Abstract
PlGF and VEGF-B exhibit dual effects on angiogenesis mediated by VEGF-A.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bevacizumab plus Irinotecan, Fluorouracil, and Leucovorin for Metastatic Colorectal Cancer
Hurwitz, H., Fehrenbacher, L., Novotny, W., Cartwright, T., Hainsworth, J., Heim, W., Berlin, J., Baron, A., Griffing, S., Holmgren, E., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa032691 · Cited by 10,968
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070 · cited 1×
“Furthermore, the impairment of VEGF-regulated vascular functions may contribute to the onset, development, and progression of several common and lethal human diseases, including cancer, cardiovascular disorders, diabetic complications, retinal degeneration, and chronic inflammation (5).”
BackgroundPaclitaxel–Carboplatin Alone or with Bevacizumab for Non–Small-Cell Lung Cancer
Sandler, A., Gray, R., Perry, M. C., Brahmer, J., Schiller, J. H., Dowlati, A., Lilenbaum, R., & Johnson, D. H. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa061884 · Cited by 5,761
Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele
Carmeliet, P., Ferreira, V., Breier, G., Pollefeyt, S., Kieckens, L., Gertsenstein, M., Fahrig, M., Vandenhoeck, A., Harpal, K., Eberhardt, C., et al. (1996) · Nature · doi:10.1038/380435a0 · Cited by 4,117
Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene
Ferrara, N., Carver-Moore, K., Chen, H., Dowd, M., Lu, L., O'Shea, K. S., Powell-Braxton, L., Hillan, K. J., & Moore, M. W. (1996) · Nature · doi:10.1038/380439a0 · Cited by 3,628
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
Miller, K., Wang, M., Gralow, J., Dickler, M., Cobleigh, M., Perez, E. A., Shenkier, T., Cella, D., & Davidson, N. E. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072113 · Cited by 3,081
Modes of resistance to anti-angiogenic therapy
Bergers, G., & Hanahan, D. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2442 · Cited by 2,953 · cited 1×
“Additionally, unconventional drug resistance— which involves compensatory switching to non–VEGF-A angiogenic factors, ligandindependent autophosphorylation of VEGF receptors, recruitment of myeloid cells, tissue hypoxia, and abnormality of tumor endothelial cells—tends to develop after relatively long periods of thera…”
BackgroundRole of the Flt-1 receptor tyrosine kinase in regulating the assembly of vascular endothelium
Fong, G.-H., Rossant, J., Gertsenstein, M., & Breitman, M. L. (1995) · Nature · doi:10.1038/376066a0 · Cited by 2,606 · cited 3×
“In contrast, deletion of the murine VEGFR1 gene (Flt1) also results in early embryonic death, but this is due to uncontrollable growth of blood vessel endothelial cells (50), which suggests that VEGFR1 mediates negative regulation of embryonic angiogenesis.”
BackgroundInfluentialSoker, S., Takashima, S., Miao, H. Q., Neufeld, G., & Klagsbrun, M. (1998) · Cell · doi:10.1016/s0092-8674(00)81402-6 · Cited by 2,463
Escudier, B., Pluzanska, A., Koralewski, P., Ravaud, A., Bracarda, S., Szczylik, C., Chevreau, C., Filipek, M., Melichar, B., Bajetta, E., et al. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61904-7 · Cited by 2,217
Kerbel, R. S. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0706596 · Cited by 1,948
Lyden, D., Hattori, K., Dias, S., Costa, C., Blaikie, P., Butros, L., Chadburn, A., Heissig, B., Marks, W., Witte, L., et al. (2001) · Nature Medicine · doi:10.1038/nm1101-1194 · Cited by 1,860
VEGF-Trap: A VEGF blocker with potent antitumor effects
Holash, J., Davis, S., Papadopoulos, N., Croll, S. D., Ho, L., Russell, M., Boland, P., Leidich, R., Hylton, D., Burova, E., et al. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.172398299 · Cited by 1,691
VEGF-targeted therapy: mechanisms of anti-tumour activity
Ellis, L. M., & Hicklin, D. J. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2403 · Cited by 1,673
Joukov, V., Pajusola, K., Kaipainen, A., Chilov, D., Lahtinen, I., Kukk, E., Saksela, O., Kalkkinen, N., & Alitalo, K. (1996) · The EMBO Journal · doi:10.1002/j.1460-2075.1996.tb00359.x · Cited by 1,672
Carmeliet, P., Moons, L., Luttun, A., Vincenti, V., Compernolle, V., De Mol, M., Wu, Y., Bono, F., Devy, L., Beck, H., et al. (2001) · Nature Medicine · doi:10.1038/87904 · Cited by 1,672
Waltenberger, J., Claesson-Welsh, L., Siegbahn, A., Shibuya, M., & Heldin, C. H. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47116-5 · Cited by 1,656
Kendall, R. L., & Thomas, K. A. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.22.10705 · Cited by 1,394
Park, J. E., Chen, H. H., Winer, J., Houck, K. A., & Ferrara, N. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)47298-5 · Cited by 1,112
Luttun, A., Tjwa, M., Moons, L., Wu, Y., Angelillo-Scherrer, A., Liao, F., Nagy, J. A., Hooper, A., Priller, J., De Klerck, B., et al. (2002) · Nature Medicine · doi:10.1038/nm731 · Cited by 1,068
Hiratsuka, S., Minowa, O., Kuno, J., Noda, T., & Shibuya, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.16.9349 · Cited by 1,062
Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor.
Maglione, D., Guerriero, V, Viglietto, G., Delli-Bovi, P., & Persico, M. G. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.20.9267 · Cited by 999
Hiratsuka, S., Nakamura, K., Iwai, S., Murakami, M., Itoh, T., Kijima, H., Shipley, J. M., Senior, R. M., & Shibuya, M. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00153-8 · Cited by 910
Vascular endothelial growth factor B, a novel growth factor for endothelial cells.
Olofsson, B., Pajusola, K., Kaipainen, A., von Euler, G., Joukov, V, Saksela, O., Orpana, A., Pettersson, R. F., Alitalo, K., & Eriksson, U. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.6.2576 · Cited by 803
Anti-PlGF Inhibits Growth of VEGF(R)-Inhibitor-Resistant Tumors without Affecting Healthy Vessels
Fischer, C., Jonckx, B., Mazzone, M., Zacchigna, S., Loges, S., Pattarini, L., Chorianopoulos, E., Liesenborghs, L., Koch, M., De Mol, M., et al. (2007) · Cell · doi:10.1016/j.cell.2007.08.038 · Cited by 779
Role of PlGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1
Autiero, M., Waltenberger, J., Communi, D., Kranz, A., Moons, L., Lambrechts, D., Kroll, J., Plaisance, S., De Mol, M., Bono, F., et al. (2003) · Nature Medicine · doi:10.1038/nm884 · Cited by 773
Hattori, K., Heissig, B., Wu, Y., Dias, S., Tejada, R., Ferris, B., Hicklin, D. J., Zhu, Z., Bohlen, P., Witte, L., et al. (2002) · Nature Medicine · doi:10.1038/nm740 · Cited by 633
Vascular endothelial growth factor is essential for corpus luteum angiogenesis
Ferrara, N., Chen, H., Davis-Smyth, T., Gerber, H.-P., Nguyen, T.-N., Peers, D., Chisholm, V., Hillan, K. J., & Schwall, R. H. (1998) · Nature Medicine · doi:10.1038/nm0398-336 · Cited by 624
Differential Roles of Vascular Endothelial Growth Factor Receptor-1 and Receptor-2 in Angiogenesis
Shibuya, M. (2006) · BMB Reports · doi:10.5483/bmbrep.2006.39.5.469 · Cited by 623
Crawford, Y., Kasman, I., Yu, L., Zhong, C., Wu, X., Modrusan, Z., Kaminker, J., & Ferrara, N. (2009) · Cancer Cell · doi:10.1016/j.ccr.2008.12.004 · Cited by 611
Gale, N. W., Dominguez, M. G., Noguera, I., Pan, L., Hughes, V., Valenzuela, D. M., Murphy, A. J., Adams, N. C., Lin, H. C., Holash, J., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407290101 · Cited by 600
VEGF as a Therapeutic Target in Cancer
Ferrara, N. (2005) · Oncology · doi:10.1159/000088479 · Cited by 578
Therapy-Induced Acute Recruitment of Circulating Endothelial Progenitor Cells to Tumors
Shaked, Y., Ciarrocchi, A., Franco, M., Lee, C. R., Man, S., Cheung, A. M., Hicklin, D. J., Chaplin, D., Foster, F. S., Benezra, R., et al. (2006) · Science · doi:10.1126/science.1127592 · Cited by 570
Vascular endothelial growth factor C induces angiogenesis in vivo
Cao, Y., Linden, P., Farnebo, J., Cao, R., Eriksson, A., Kumar, V., Qi, J.-H., Claesson-Welsh, L., & Alitalo, K. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14389 · Cited by 565
Self-citationBlocking Neuropilin-1 Function Has an Additive Effect with Anti-VEGF to Inhibit Tumor Growth
Pan, Q., Chanthery, Y., Liang, W.-C., Stawicki, S., Mak, J., Rathore, N., Tong, R. K., Kowalski, J., Yee, S. F., Pacheco, G., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.10.018 · Cited by 532
Seetharam, L., Gotoh, N., Maru, Y., Neufeld, G., Yamaguchi, S., & Shibuya, M. (1995) · PubMed · Cited by 464
Enholm, B., Paavonen, K., Ristimäki, A., Kumar, V., Gunji, Y., Klefstrom, J., Kivinen, L., Laiho, M., Olofsson, B., Joukov, V., et al. (1997) · Oncogene · doi:10.1038/sj.onc.1201090 · Cited by 457
Goldman, C. K., Kendall, R. L., Cabrera, G., Soroceanu, L., Heike, Y., Gillespie, G. Y., Siegal, G. P., Mao, X., Bett, A. J., Huckle, W. R., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.15.8795 · Cited by 443
Rini, B. I., Michaelson, M. D., Rosenberg, J. E., Bukowski, R. M., Sosman, J. A., Stadler, W. M., Hutson, T. E., Margolin, K., Harmon, C. S., DePrimo, S. E., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.5416 · Cited by 393
Hiratsuka, S., Maru, Y., Okada, A., Seiki, M., Noda, T., & Shibuya, M. (2001) · PubMed · Cited by 388
Sasaki, K., Yagi, H., Bronson, R. T., Tominaga, K., Matsunashi, T., Deguchi, K., Tani, Y., Kishimoto, T., & Komori, T. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.22.12359 · Cited by 368
Ebos, J. M. L., Lee, C. R., Christensen, J. G., Mutsaers, A. J., & Kerbel, R. S. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0708148104 · Cited by 367
Maglione, D. (1991) · Medical Entomology and Zoology · Cited by 352
Neuropilin-1 Is a Placenta Growth Factor-2 Receptor
Migdal, M., Huppertz, B., Tessler, S., Comforti, A., Shibuya, M., Reich, R., Baumann, H., & Neufeld, G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.35.22272 · Cited by 348
Blocking Neuropilin-2 Function Inhibits Tumor Cell Metastasis
Caunt, M., Mak, J., Liang, W.-C., Stawicki, S., Pan, Q., Tong, R. K., Kowalski, J., Ho, C., Reslan, H. B., Ross, J., et al. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.01.029 · Cited by 343
Dvorak, H. F., Detmar, M., Claffey, K. P., Nagy, J. A., van de Water, L., & Senger, D. R. (1995) · International Archives of Allergy and Immunology · doi:10.1159/000236988 · Cited by 333
Bellomo, D., Headrick, J. P., Silins, G. U., Paterson, C. A., Thomas, P. S., Gartside, M., Mould, A., Cahill, M. M., Tonks, I. D., Grimmond, S. M., et al. (2000) · Circulation Research · doi:10.1161/01.res.86.2.e29 · Cited by 333
Li, B., Sharpe, E. E., Maupin, A. B., Teleron, A. A., Pyle, A. L., Carmeliet, P., Young, P. P., Li, B., Sharpe, E. E., Maupin, A. B., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-5137fje · Cited by 324
Orlandini, M., Marconcini, L., Ferruzzi, R., & Oliviero, S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.21.11675 · Cited by 315
Molecular mechanisms of preeclampsia
Mutter, W. P., & Karumanchi, S. A. (2008) · Microvascular Research · doi:10.1016/j.mvr.2007.04.009 · Cited by 314
Maglione, D., Guerriero, V., Viglietto, G., Ferraro, M. G., Aprelikova, O. N., Alitalo, K. K., Vecchio, S. D., Lei, K. J., Chou, J. Y., & Persico, M. G. (1993) · PubMed · Cited by 313
Makinen, T., Olofsson, B., Karpanen, T., Hellman, U., Soker, S., Klagsbrun, M., Eriksson, U., & Alitalo, K. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.30.21217 · Cited by 310
Heterodimers of Placenta Growth Factor/Vascular Endothelial Growth Factor
Cao, Y., Chen, H., Zhou, L., Chiang, M.-K., Anand-Apte, B., Weatherbee, J. A., Wang, Y., Fang, F., Flanagan, J. G., & Tsang, M. L.-S. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.6.3154 · Cited by 295
Self-citationVascular endothelial grouth facter B, a novel growth facter for endothelial cells
Olffson, B. (1996) · Medical Entomology and Zoology · Cited by 279
Placenta growth factor-1 is chemotactic, mitogenic, and angiogenic.
Ziche, M., Maglione, D., Ribatti, D., Morbidelli, L., Lago, C. T., Battisti, M., Paoletti, I., Barra, A., Tucci, M., Parise, G., et al. (1997) · PubMed · Cited by 277
Mamluk, R., Gechtman, Z., Kutcher, M. E., Gasiunas, N., Gallagher, J., & Klagsbrun, M. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m200730200 · Cited by 260
Hauser, S., & Weich, H. A. (1993) · Growth Factors · doi:10.3109/08977199308991586 · Cited by 245
Olofsson, B., Pajusola, K., von Euler, G., Chilov, D., Alitalo, K., & Eriksson, U. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19310 · Cited by 218
R Regulation of tumor angiogenesis and metastasis by FGF and PDGF signaling pathways
Cao, Y., Cao, R., & Hedlund, E.-M. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0337-z · Cited by 215
Self-citationIn vitro hematopoietic and endothelial potential of flk-1 −/− embryonic stem cells and embryos
Schuh, A. C., Faloon, P., Hu, Q.-L., Bhimani, M., & Choi, K. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.5.2159 · Cited by 213
Placental growth factor is a survival factor for tumor endothelial cells and macrophages.
Adini, A., Kornaga, T., Firoozbakht, F., & Benjamin, L. E. (2002) · PubMed · Cited by 212
Cao, Y., Linden, P., Shima, D., Browne, F., & Folkman, J. (1996) · Journal of Clinical Investigation · doi:10.1172/jci119069 · Cited by 211
Self-citationViglietto, G., Maglione, D., Rambaldi, A., Cerutti, J. M., Romano, A., Trapasso, F., Fedele, M., Ippolito, P., Chiappetta, G., & Botti, G. (1995) · PubMed · Cited by 208
Mice overexpressing placenta growth factor exhibit increased vascularization and vessel permeability
Odorisio, T., Schietroma, C., Zaccaria, M. L., Cianfarani, F., Tiveron, C., Tatangelo, L., Failla, C. M., & Zambruno, G. (2002) · Journal of Cell Science · doi:10.1242/jcs.115.12.2559 · Cited by 203
LUTTUN, A., TJWA, M., & CARMELIET, P. (2002) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2002.tb04870.x · Cited by 202
Eriksson, A., Cao, R., Pawliuk, R., Berg, S.-M., Tsang, M., Zhou, D., Fleet, C., Tritsaris, K., Dissing, S., Leboulch, P., et al. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00028-4 · Cited by 198
Self-citationVascular Endothelial Growth Factor-B–Deficient Mice Display an Atrial Conduction Defect
Aase, K., von Euler, G., Li, X., Pontén, A., Thorén, P., Cao, R., Cao, Y., Olofsson, B., Gebre-Medhin, S., Pekny, M., et al. (2001) · Circulation · doi:10.1161/01.cir.104.3.358 · Cited by 197
Self-citationCao, Y., Ji, W.-R., Qi, P., Rosin, Å., & Cao, Y. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.6813 · Cited by 196
Self-citationLi, Y., Zhang, F., Nagai, N., Tang, Z., Zhang, S., Scotney, P., Lennartsson, J., Zhu, C., Qu, Y., Fang, C., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33673 · Cited by 194
Self-citationYonekura, H., Sakurai, S., Liu, X., Migita, H., Wang, H., Yamagishi, S.-I., Nomura, M., Abedin, M. J., Unoki, H., Yamamoto, Y., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.49.35172 · Cited by 194
Green, C. J., Lichtlen, P., Huynh, N., Yanovsky, M., Laderoute, K. R., Schaffner, W., & Murphy, B. J. (2001) · PubMed · Cited by 179
Vascular Endothelial Growth Factor-A Promotes Peritumoral Lymphangiogenesis and Lymphatic Metastasis
Björndahl, M. A., Cao, R., Burton, J. B., Brakenhielm, E., Religa, P., Galter, D., Wu, L., & Cao, Y. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-2345 · Cited by 178
Self-citationLandgren, E., Schiller, P., Cao, Y., & Claesson-Welsh, L. (1998) · Oncogene · doi:10.1038/sj.onc.1201545 · Cited by 168
Self-citationMurakami, M., Iwai, S., Hiratsuka, S., Yamauchi, M., Nakamura, K., Iwakura, Y., & Shibuya, M. (2006) · Blood · doi:10.1182/blood-2006-04-016030 · Cited by 166
The Interaction of Neuropilin-1 and Neuropilin-2 with Tyrosine-Kinase Receptors for VEGF
Neufeld, G., Kessler, O., & Herzog, Y. (2002) · Advances in Experimental Medicine and Biology · doi:10.1007/978-1-4615-0119-0_7 · Cited by 164
Liu, L., Marti, G. P., Wei, X., Zhang, X., Zhang, H., Liu, Y. V., Nastai, M., Semenza, G. L., & Harmon, J. W. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21503 · Cited by 162
Flt-1 Signaling in Macrophages Promotes Glioma Growth In vivo
Kerber, M., Reiss, Y., Wickersheim, A., Jugold, M., Kiessling, F. M., Heil, M., Tchaikovski, V., Waltenberger, J. L., Shibuya, M., Plate, K. H., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6241 · Cited by 156
Sakaue-Sawano, A., Takahashi, T., Yamaguchi, S., & Shibuya, M. (1997) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1997.7327 · Cited by 152
Miyamoto, N., de Kozak, Y., Jeanny, J., Glotin, A., Mascarelli, F., Massin, P., BenEzra, D., & Béhar‐Cohen, F. (2006) · Diabetologia · doi:10.1007/s00125-006-0539-2 · Cited by 152
Cloning and characterization of a novel human gene related to vascular endothelial growth factor.Preprint
Grimmond, S. M., Lagercrantz, J., Drinkwater, C. C., Silins, G. U., Townson, S. M., Pollock, P. M., Gotley, D. C., Carson, E., Rakar, S., Nordenskjöld, M., et al. (1996) · Genome Research · doi:10.1101/gr.6.2.124 · Cited by 149
Combination angiostatic therapy completely inhibits ocular and tumor angiogenesis
Dorrell, M. I., Aguilar, E., Scheppke, L., Barnett, F. H., & Friedlander, M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607542104 · Cited by 147
Is angiogenesis an organizing principle in biology and medicine?
Folkman, J. (2007) · Journal of Pediatric Surgery · doi:10.1016/j.jpedsurg.2006.09.048 · Cited by 144
Dimerization of VEGF receptors and implications for signal transduction: A computational study
Gabhann, F. M., & Popel, A. S. (2007) · Biophysical Chemistry · doi:10.1016/j.bpc.2007.03.010 · Cited by 142
Placenta growth factor is over-expressed and has prognostic value in human breast cancer
Parr, C., Watkins, G., Boulton, M. E., Cai, J., & Jiang, W. G. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.07.022 · Cited by 140
Properties of Two VEGF Receptors, Flt‐1 and KDR, in Signal Transductiona
Sato, Y., Kanno, S., Oda, N., Abé, M., Ito, M., Shitara, K., & Shibuya, M. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06314.x · Cited by 139
血小板由来増殖因子/血管内皮増殖因子ファミリーと相関するc‐fos誘導性遺伝子の同定
Orlandini, M., Marconcini, L., Ferruzzi, R., & Oliviero, S. (1996) · Cited by 138
Cunningham, S. A., Waxham, M. N., Arrate, M. P., & Brock, T. A. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.35.20254 · Cited by 137
Chen, C., Hsieh, F., Cheng, Y.-M., Cheng, W.-F., Su, Y.-N., Chang, K., & Lee, P. (2004) · Cancer Letters · doi:10.1016/j.canlet.2004.05.020 · Cited by 131
Cai, J., Ahmad, S., Jiang, W. G., et al. (2003) · Diabetes · doi:10.2337/diabetes.52.12.2959 · Cited by 131
Placenta growth factor expression is correlated with survival of patients with colorectal cancer
Wei, S.-C., Tsao, P.-N., Yu, S.-C., Shun, C.-T., Tsai-Wu, J.-J., Wu, C. H. H., Su, Y.-N., Hsieh, F.-J., & Wong, J.-M. (2005) · Gut · doi:10.1136/gut.2004.050831 · Cited by 128
The Molecular Basis of VEGFR-1 Signal Transduction Pathways in Primary Human Monocytes
Tchaikovski, V., Fellbrich, G., & Waltenberger, J. L. (2007) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.107.158022 · Cited by 124
Witt, C. M., Won, W.-J., Hurez, V. J., & Klug, C. A. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.6.2783 · Cited by 124
Increased Melanoma Growth and Metastasis Spreading in Mice Overexpressing Placenta Growth Factor
Marcellini, M., Luca, N. D., Riccioni, T., Ciucci, A., Orecchia, A., Lacal, P. M., Ruffini, F., Pesce, M., Cianfarani, F., Zambruno, G., et al. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.051041 · Cited by 106
Placenta Growth Factor is Induced in Human Keratinocytes during Wound Healing
Failla, C. M., Odorisio, T., Cianfarani, F., Schietroma, C., Zambruno, G., & Puddu, P. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00085.x · Cited by 106
Tew, W. P., Colombo, N., Ray-Coquard, I. L., Oza, A. M., del Campo, J., Scambia, G., & Spriggs, D. R. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.25.18_suppl.5508 · Cited by 106
The biology of vascular endothelial growth factor-B (VEGF-B)
Nash, A. D., Baca, M., Wright, C. E., & Scotney, P. D. (2005) · Pulmonary Pharmacology & Therapeutics · doi:10.1016/j.pupt.2005.02.007 · Cited by 103
Ecstasy danger hits the headlines
Jones, R. (2002) · Nature reviews. Neuroscience · doi:10.1038/nrn974 · Cited by 103
Yang, W., Ahn, H., Hinrichs, M., Torry, R. J., & Torry, D. S. (2003) · Journal of Reproductive Immunology · doi:10.1016/s0165-0378(03)00082-2 · Cited by 102
Luttun, A., Brusselmans, K., Fukao, H., Tjwa, M., Ueshima, S., Herbert, J., Matsuo, O., Collen, D., Carmeliet, P., & Moons, L. (2002) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(02)00677-0 · Cited by 93
Xu, L., Cochran, D., Tong, R. T., Winkler, F., Kashiwagi, S., Jain, R. K., & Fukumura, D. (2006) · Cancer Research · doi:10.1158/0008-5472.can-04-3085 · Cited by 89
Gleadle, J., Ebert, B. L., & Ratcliffe, P. J. (1995) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1995.092_c.x · Cited by 88
Bellik, L., Vinci, M. C., Filippi, S., Ledda, F., & Parenti, A. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706347 · Cited by 81
A Very Effective Treatment for Neovascular Macular Degeneration
Stone, E. M. (2006) · New England Journal of Medicine · doi:10.1056/nejme068191 · Cited by 74
Ho, M., Chen, C., Lee, H., Hsieh, F., Shun, C., Chang, C., Lai, Y.-T., & Lee, P. (2006) · Cancer Letters · doi:10.1016/j.canlet.2006.10.005 · Cited by 69
List, A. F., Glinsmann‐Gibson, B., Stadheim, C., Meuillet, E. J., Bellamy, W. T., & Powis, G. (2004) · Experimental Hematology · doi:10.1016/j.exphem.2004.03.005 · Cited by 63
Vascular Endothelial Growth Factor Trap in Non–Small Cell Lung Cancer
Riely, G. J., & Miller, V. A. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0544 · Cited by 59
Blockage of VEGF-Induced Angiogenesis by Preventing VEGF Secretion
Björndahl, M. A., Cao, R., Eriksson, A., & Cao, Y. (2004) · Circulation Research · doi:10.1161/01.res.0000129194.61747.bf · Cited by 58
Self-citationDupont, J., Schwartz, L., Koutcher, J. A., Spriggs, D. R., Gordon, M. S., Mendelson, D. S., Murren, J., Lucarelli, A., & Cedarbaum, J. M. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.22.14_suppl.3009 · Cited by 56
Cheng, L., Jia, H., Löhr, M., Bagherzadeh, A., Holmes, D. I. R., Selwood, D. L., & Zachary, I. C. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402488200 · Cited by 52
Schomber, T., Kopfstein, L., Djonov, V., Albrecht, I., Baeriswyl, V., Strittmatter, K., & Christofori, G. (2007) · Cancer Research · doi:10.1158/0008-5472.can-07-1034 · Cited by 52
de Groot, J., Wen, P. Y., Lamborn, K. R., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.2020 · Cited by 49
Shaked, Y., Bocci, G., Muñoz, R., Man, S., Ebos, J. M. L., Hicklin, D. J., Bertolini, F., D’Amato, R. J., & Kerbel, R. S. (2005) · Current Cancer Drug Targets · doi:10.2174/156800905774574020 · Cited by 46
Automated Evaluation of Angiogenic Effects Mediated by VEGF and PlGF Homo- and Heterodimers
Kurz, H., Wilting, J., Sandau, K., & Christ, B. (1998) · Microvascular Research · doi:10.1006/mvre.1997.2051 · Cited by 46
Human retinal epithelium produces and responds to placenta growth factor
Hollborn, M., Tenckhoff, S., Seifert, M., Köhler, S., Wiedemann, P., Bringmann, A., & Kohen, L. (2005) · Graefe s Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s00417-005-0154-9 · Cited by 46
Freyer, G., Fumoleau, P., You, B., Isambert, N., Chevalier, P., & Lenoir, V. T. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.14539 · Cited by 44
Tang, P. A., Cohen, S. J., Bjarnason, G. A., Kollmannsberger, C., Virik, K., MacKenzie, M. J., Brown, J., Wang, L., Chen, A. P., & Moore, M. J. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.4027 · Cited by 37
Isambert, N., Freyer, G., Zanetta, S., Falandry, C., Soussan-Lazard, K., & Fumoleau, P. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.3599 · Cited by 35
Elevation of plasma placental growth factor in the patients with ischemic cardiomyopathy
Nakamura, T., Funayama, H., Kubo, N., Yasu, T., Kawakami, M., Momomura, S., & Ishikawa, S. (2008) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.10.050 · Cited by 34
Nishimoto, F., Sakata, M., Minekawa, R., Okamoto, Y., Miyake, A., Isobe, A., Yamamoto, T., Takeda, T., Ishida, E., Sawada, K., et al. (2008) · Endocrinology · doi:10.1210/en.2008-0949 · Cited by 31
Aortic Pulse Pressure and Aortic Pulsatility in Patients with Coronary Slow Flow
Güray, Ü., Guray, Y. A., Yılmaz, M. B., Çaldır, V., Çay, S., Şaşmaz, H., & Kormaz, S. (2006) · Cardiology · doi:10.1159/000095423 · Cited by 31
VEGF-receptor inhibitors for anti-angiogenesis.
Shibuya, M. (2003) · Folia Pharmacologica Japonica · doi:10.1254/fpj.122.498 · Cited by 28
Taylor, A. P., Osorio, L., Craig, R., Raleigh, J. A., Ying, Z., Goldenberg, D. M., & Blumenthal, R. D. (2002) · PubMed · Cited by 24
Limentani, S. A., Just, R. G., Purdham, A., Mulay, M., Bair, A., Tamby, J., Chap, L. I., & Rosen, L. S. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.3556 · Cited by 18
Rixe, O., Verslype, C., Khayat, D., Tejpar, S., Billemont, B., Crabbé, M., Méric, J., Assadourian, S., & Cutsem, E. V. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.3557 · Cited by 16
Patnaik, A., Pipas, M., Rosen, L. S., Wood, L., Phipps, K., Mulay, M., Garay, C. A., Korc, M., & Sarantopoulos, J. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.26.15_suppl.3558 · Cited by 14
Cited by
Papadopoulos, N., Martin, J., Ruan, Q., Rafique, A., Rosconi, M. P., Shi, E., Pyles, E. A., Yancopoulos, G. D., Stahl, N., & Wiegand, S. J. (2012) · Angiogenesis · doi:10.1007/s10456-011-9249-6 · Cited by 1,037
Targeting Angiogenesis in Cancer Therapy: Moving Beyond Vascular Endothelial Growth Factor
Zhao, Y., & Adjei, A. A. (2015) · The Oncologist · doi:10.1634/theoncologist.2014-0465 · Cited by 558
Molecular Pharmacology of VEGF-A Isoforms: Binding and Signalling at VEGFR2
Peach, C. J., Mignone, V. W., Arruda, M. A., Alcobia, D. C., Hill, S. J., Kilpatrick, L. E., & Woolard, J. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19041264 · Cited by 512
Adipose tissue angiogenesis as a therapeutic target for obesity and metabolic diseases
Cao, Y. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd3055 · Cited by 442
Self-citationBlood vessel formation and function in bone
Sivaraj, K. K., & Adams, R. H. (2016) · Development · doi:10.1242/dev.136861 · Cited by 441
Metadata
- Authors
- Cao, Y.
- Venue
- Science Signaling
- Published
- 2009-02-24
- Volume
- 2
- Issue
- 59
- Pages
- re1-re1
- ISSN
- 1937-9145 (ISSN-L)
- 1945-0877
- OpenAlex
- W2147407942
- Cited by
- 289
- References
- 125
- FWCI
- 9.48
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.